Prevalence of BER gene polymorphisms in sporadic breast cancer

Oncology Reports

Volumn 19, Issue 4, 2008, Pages 1033-1038

  Ali, Mohamed F ^a   Meza, Jane L ^b   Rogan, Eleanor G ^a   Chakravarti, Dhrubajyoti ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

APE1; Breast cancer; LIG3; PARP1; Polymorphism; XRCC1

Indexed keywords

ARGININE; ASPARTIC ACID; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; GLUTAMINE; GLYCINE; HISTIDINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROLINE; SERINE; TRYPTOPHAN; XRCC1 PROTEIN; APEX1 PROTEIN, HUMAN; DNA BINDING PROTEIN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1;

ARTICLE; BREAST CANCER; BREAST RECONSTRUCTION; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EUROPE; EXCISION REPAIR; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC VARIABILITY; HETEROZYGOTE; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SOMATIC MUTATION; UNITED STATES; WILD TYPE; BREAST TUMOR; DNA REPAIR; GENETIC POLYMORPHISM; GENETICS; GENOTYPE;

BREAST NEOPLASMS; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; FEMALE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC;

EID: 43849104497     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.4.1033     Document Type: Article

References (46)

1. Lindahl T: Suppression of spontaneous mutagenesis in human cells by DNA base excision-repair. Mutat Res 462: 129-135, 2000.
2. Chakravarti D, Mailander P, Eranzen J, Higginbotham S, Cavalieri EL and Rogan EG: Detection of dibenzo pyrene-induced H-ras codon 61 mutant genes in preneoplastic SENCAR mouse skin using a new PCR-RFLP method. Oncogene 16: 3203-3210, 1998.
3. Chakravarti D, Mailander PC, Cavalieri EL and Rogan EG: Evidence that error-prone DNA repair converts dibenzo]pyrene-induced depurinating lesions into mutations: formation, clonal proliferation and regression of initiated cells carrying H-ras oncogene mutations in early preneoplasia. Mutat Res 456: 17-32, 2000.
4. Chakravarti D, Mailander PC, Li K-M, Higginbotham S, Zhang HL, Gross ML, Meza JL, Cavalieri EL and Rogan EG: Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene. Oncogene 20: 7945-7953, 2001.
5. Mailander PC, Meza JL, Higginbotham S and Chakravarti D: Induction of A.T to G.C mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of ACI rats. J Steroid Biochem Mol Biol 101: 204-215, 2006.
6. Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R and Sutter T: Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 1766: 63-78, 2006.
7. Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, Ramanathan R, Cerny RL and Rogan EG: Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 94: 10937-10942, 1997.
8. Rogan EG, Badawi AF, Devanesan PD, Meza JL, Edney JA, West WW, Higginbotham SM and Cavalieri EL: Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis 24: 697-702, 2003.
9. Singh S, Chakravarti D, Edney JA, Hollins RR, Johnson PJ, West WW, Higginbotham SM, Cavalieri EL and Rogan EG: Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma. Oncol Rep 14: 1091-1096, 2005.
10. Hung RJ, Hall J, Brennan P and Boffetta P: Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162: 925-942, 2005.
11. Breast Cancer Association Consortinm: Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst 98: 1382-1396, 2006.
12. Choi JY, Hamajima N, Tajima K, Yoo KY, Yoon KS, Park SK, Kim SU, Lee KM, Noh DY, Ahn SH, Choe KJ, Han W, Hirvonen A and King D: hOGG1 Ser326Cys polymorphism and breast cancer risk among Asian women. Breast Cancer Res Treat 79: 59-62, 2003.
13. Vogel U, Nexo BA, Olsen A, Thomsen B, Jacobsen NR, Wallin H, Overvad K and Tjonneland A: No association between OGG1 Ser326Cys polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prey 12: 170-171, 2003.
14. Zhang Y, Newcomb PA, Egan KM, Titus-Ernstoff L, Chanock S, Welch R, Brinton LA, Lissowska J, Bardin-Mikolajczak A, Peplonska B, Szeszenia-Dabrowska N, Zatonski W and Garcia-Closas M: Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prey 15: 353-358, 2006.
15. Duell EJ, Millikan RC, Pittman GS, Winkel S, Lunn RM, Tse CK, Eaton A, Mohrenweiser HW, Newman B and Bell DA: Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev 10: 217-222, 2001.
16. Chacko P, Rajan B, Joseph T, Mathew BS and Pillai MR: Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat 89: 15-21, 2005.
17. Kim SU, Park SK, Yoo KY, Yoon KS, Choi JY, Seo JS, Park WY, Kim JH, Noh DY, Ahn SH, Choe KJ, Strickland PT, Hirvonen A and Kang D: XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics 12: 335-338, 2002.
18. Deligezer U and Dalay N: Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patients. Exp Mol Med 36: 572-575, 2004.
19. Zhai X, Liu J, Hu Z, Wang S, Qing J, Wang X, Jin G, Gao J and Shen H: Polymorphisms of ADPRT Val762Ala and XRCC1 Arg399Gln and risk of breast cancer in Chinese women: a case control analysis. Oncol Rep 15: 247-252, 2006.
20. Smith TR, Levine EA, Perrier ND, Miller MS, Freimanis RI, Lohman K, Case LD, Xu J, Mohrenweiser HW and Hu JJ: DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 12: 1200-1204, 2003.
21. Pachkowski BF, Winkel S, Kubota Y, Swenberg JA, Millikan RC and Nakamura J: XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res 66: 2860-2868, 2006.
22. Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R and Schmitt F: DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat 103: 209-217, 2007.
23. Taylor RM, Thistlethwaite A and Caldecott KW: Central role for the XRCC1 BRCT 1 domain in mammalian DNA single-strand break repair. Mol Cell Biol 22: 2556-2563, 2002.
24. Casse C, Hu YC and Ahrendt SA: The XRCC1 codon 399 Gln allele is associated with adenine to guanine p53 mutations in non-small cell lung cancer. Mutat Res 528: 19-27, 2003.
25. Hsieh LL, Chien HT, Chen IH, Liao CT, Wang HM, Jung SM, Wang PF, Chang JT, Chen MC and Cheng AJ: The XRCC1 399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 12: 439-443, 2003.
26. Shen MR, Zdzienicka MZ, Mohrenweiser H, Thompson LH and Thelen MP: Mutations in hamster single-strand break repair gene XRCC1 causing defective DNA repair. Nucleic Acids Res 26: 1032-1037, 1998.
27. Lunn RM, Langlois RG, Hsieh LL, Thompson CL and Bell DA: XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59: 2557-2561, 1999.
28. Butkiewicz D, Rusin M, Enewold L, Shields PG, Chorazy M and Harris CC: Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 22: 593-597, 2001.
29. Stern MC, Umbach DM, van Gils CH, Lunn RM and Taylor JA: DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 10: 125-131, 2001.
30. American Cancer Society: Cancer Facts and Figures -2007. American Cancer Society, Atlanta, pp1-56, 2007.
31. Vidal AE, Boiteux S, Hickson ID and Radicella JP: XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J 20: 6530-6539, 2001.
32. Moullan N, Cox DG, Angele S, Romestaing P, Gerard JP and Hall J: Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 12: 1168-1174, 2003.
33. Metsola K, Kataja V, Sillanpaa P, Siivola P, Heikinheimo L, Eskelinen M, Kosma VM, Uusitupa M and Hirvonen A: XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res 7: R987-R997, 2005.
34. Shen J, Gammon MD, Terry MB, Wang L, Wang Q, Zhang F, Teitelbaum SL, Eng SM, Sagiv SK, Gaudet MM, Neugut AI and Santella RM: Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14: 336-342, 2005.
35. Chakravarti D, Badawi AF, Venugopal D, Meza JL, Crandall LZ, Rogan EG and Cavalieri EL: Improved measurement of dibenzo]pyrene-induced abasic sites by the aldehyde-reactive probe assay. Mutat Res 588: 158-165, 2005.
36. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS: 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 19: 4008, 1991.
37. Lee JM, Lee YC, Yang SY, Yang PW, Luh SP, Lee CJ, Chen CJ and Wu MT: Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Intl Cancer 95: 240-246, 2001.
38. Sturgis EM, Castillo EJ, Li L, Zheng R, Eicher SA, Clayman GL, Strom SS, Spitz MR and Wei Q: Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 20: 2125-2129, 1999.
39. Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A and Case LD: Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 22: 917-922, 2001.
40. Li C, Liu Z, Wang LE, Strom SS, Lee JE, Gershenwald JE, Ross MI, Mansfield PF, Cormier JN, Prieto VG, Duvic M, Grimm EA and Wei Q: Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma. Carcinogenesis 27: 1894-1901, 2006.
41. Shu XO, Cai Q, Gao YT, Wen W, Jin F and Zheng W: A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 12: 1462-1467, 2003.
42. Chang-Claude J, Popanda O, Tan XL, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P and Ambrosone CB: Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 11: 4802-4809, 2005.
43. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, Phillips DH, Canzian F and Haugen A: Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27: 560-567, 2006.
44. Forsti A, Angelini S, Festa F, Sanyal S, Zhang Z, Grzybowska E, Pamula J, Pekala W, Zientek H, Hemminki K and Kumar R: Single nucleotide polymorphisms in breast cancer. Oncol Rep 11: 917-922, 2004.
45. Masson M, Niedergang C, Schreiber V, Muller S, Menissier-de Murcia J and de Murcia G: XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 18: 3563-3571, 1998.
46. Marsin S, Vidal AE, Sossou M, Menissier-de Murcia J, Le Page F, Boiteux S, de Murcia G and Radicella JP: Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1. J Biol Chem 278: 44068-44074, 2003.